厦门港务 (000905.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

34.2x

Market Cap

CNY 13.17B

MomentumView details →

1D Return

−0.35%

YTD Return

−28.62%

RSI (14)

66.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

34.2x

Market Cap

CNY 13.17B

RSI (14)

66.0

MomentumView details →

1D Return

−0.35%

YTD Return

−28.62%

ProfitabilityView details →

Gross Margin

3.06%

Net Margin

0.89%

EBITDA Margin

2.95%

ROE (TTM)

2.24%

ROA (TTM)

0.76%

Asset Turnover

0.85x

GrowthView details →

Revenue YoY

+11.00%

EPS YoY

−43.06%

FCF YoY

—

Revenue CAGR 3Y

+0.20%

EPS CAGR 3Y

−9.23%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.54x

Current Ratio

0.84x

Quick Ratio

0.53x

Div Yield

1.34%

Div Rate

CNY 0.13

Div Growth 1Y

−36.36%

Financials snapshotView financials →

Revenue (TTM)

23.04B

Net Income (TTM)

205.19M

Op. CF (TTM)

722.08M

Latest newsMore news →

Xiamen Port Development proposed a cash dividend of 1.06 yuan per 10 shares (tax included), based on a base of 1.542 billion shares.10d ago

Xiamen Port Development announced its first-half 2026 results: revenue of 11.443 billion yuan, down 2.92% year-on-year; net profit attributable to shareholders of 348 million yuan, down 5.96% year-on-year; non-recurring-adjusted net profit of 254 million yuan, up 123.45% year-on-year.10d ago

Similar companies

百洋医药301015.SZ 周大生002867.SZ 力源信息300184.SZ 江苏国泰002091.SZ 国药一致000028.SZ 北方国际000065.SZ Find similar companies →

Latest newsMore news →

Xiamen Port Development proposed a cash dividend of 1.06 yuan per 10 shares (tax included), based on a base of 1.542 billion shares.10d ago Xiamen Port Development announced its first-half 2026 results: revenue of 11.443 billion yuan, down 2.92% year-on-year; net profit attributable to shareholders of 348 million yuan, down 5.96% year-on-year; non-recurring-adjusted net profit of 254 million yuan, up 123.45% year-on-year.10d ago